Volcano's forward-looking IVUS system.
May 24, 2010 – New intravascular imaging innovations, such as registered angiography and intravascular ultrasound (IVUS), forward-looking IVUS and a combined IVUS/balloon catheter will be highlighted May 25-28 at EuroPCR in Paris.
Volcano Corp. will spotlight new product launches and its works in progress at the conference. The new product introductions include:
• The Eagle Eye Platinum IVUS catheter, offering improved deliverability and additional radiopaque markers
• PrimeWire Prestige fractional flow reserve (FFR) wire with enhanced torque response, vessel navigation and support for treating multivessel disease
• The s5/s5i 3.2 software, which streamlines the workflow for both IVUS and FFR procedures
The company will also highlight its pipeline of imaging and therapy products. These including the Vibe RX Vascular Imaging Balloon Catheter (which is awaiting CE Mark approval), optical coherence tomography (OCT), and its Forward Looking IVUS (FL IVUS) system.
Volcano and Siemens will demonstrate continued development efforts to bring imaging co-registration to interventional cardiology. This technology will allow physicians to see their angiographic roadmap images linked side-by-side with the corresponding IVUS images in the cath lab. Siemens plans to demonstrate the co-registration application from a live case in Erasmus University Medical Center in Rotterdam, the Netherlands.
Updates on several of Volcano’s clinical trials are also being presented. These include
• VICTORY (VH In Carotids Observational Registry), a European, multicenter prospective registry for carotid plaque characterization by Virtual Histology IVUS (VH IVUS) during carotid stenting.
• HEAVEN (Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration) is a Czech, prospective, randomized, multicenter controlled study that uses VH IVUS to measure the changes of plaque volume and the changes of plaque composition during atorvastatin and ezetimibe administration to the patient with stable angina.
For more information: www.volcanocorp.com
November 07, 2024 
